Enorama Pharma Stock Forecast - Polynomial Regression
| ERMA Stock | SEK 3.26 0.04 1.21% |
The Polynomial Regression forecasted value of Enorama Pharma AB on the next trading day is expected to be 3.04 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 7.83. Enorama Stock Forecast is based on your current time horizon.
Enorama |
Enorama Pharma Polynomial Regression Price Forecast For the 13th of December 2024
Given 90 days horizon, the Polynomial Regression forecasted value of Enorama Pharma AB on the next trading day is expected to be 3.04 with a mean absolute deviation of 0.13, mean absolute percentage error of 0.03, and the sum of the absolute errors of 7.83.Please note that although there have been many attempts to predict Enorama Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Enorama Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Enorama Pharma Stock Forecast Pattern
| Backtest Enorama Pharma | Enorama Pharma Price Prediction | Buy or Sell Advice |
Enorama Pharma Forecasted Value
In the context of forecasting Enorama Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Enorama Pharma's downside and upside margins for the forecasting period are 0.03 and 8.16, respectively. We have considered Enorama Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Enorama Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Enorama Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.4046 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1262 |
| MAPE | Mean absolute percentage error | 0.0318 |
| SAE | Sum of the absolute errors | 7.8251 |
Predictive Modules for Enorama Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enorama Pharma AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Enorama Pharma
For every potential investor in Enorama, whether a beginner or expert, Enorama Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enorama Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enorama. Basic forecasting techniques help filter out the noise by identifying Enorama Pharma's price trends.Enorama Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enorama Pharma stock to make a market-neutral strategy. Peer analysis of Enorama Pharma could also be used in its relative valuation, which is a method of valuing Enorama Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Enorama Pharma AB Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Enorama Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Enorama Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Enorama Pharma Market Strength Events
Market strength indicators help investors to evaluate how Enorama Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enorama Pharma shares will generate the highest return on investment. By undertsting and applying Enorama Pharma stock market strength indicators, traders can identify Enorama Pharma AB entry and exit signals to maximize returns.
| Accumulation Distribution | 668.86 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 3.18 | |||
| Day Typical Price | 3.21 | |||
| Price Action Indicator | 0.06 | |||
| Period Momentum Indicator | (0.04) |
Enorama Pharma Risk Indicators
The analysis of Enorama Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enorama Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enorama stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.85 | |||
| Standard Deviation | 5.07 | |||
| Variance | 25.67 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Enorama Stock Analysis
When running Enorama Pharma's price analysis, check to measure Enorama Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enorama Pharma is operating at the current time. Most of Enorama Pharma's value examination focuses on studying past and present price action to predict the probability of Enorama Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enorama Pharma's price. Additionally, you may evaluate how the addition of Enorama Pharma to your portfolios can decrease your overall portfolio volatility.